Telesis Bio Financials

Telesis Bio Stock Summary

Telesis Bio competes with Biglari Holdings, El Pollo, BJs Restaurants, Dennys Corp, and National Beverage. Translate Bio, Inc., a clinical-stage messenger RNA therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company was founded in 2011 and is headquartered in Lexington, Massachusetts. Translate Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people.

Telesis Bio Key Financial Ratios

Telesis Bio's financial ratios allow both analysts and investors to convert raw data from Telesis Bio's financial statements into concise, actionable information that can be used to evaluate the performance of Telesis Bio over time and compare it to other companies across industries.

Telesis Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Telesis Bio's current stock value. Our valuation model uses many indicators to compare Telesis Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Telesis Bio competition to find correlations between indicators driving Telesis Bio's intrinsic value. More Info.Telesis Bio is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Telesis Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Telesis Bio's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

If you are still planning to invest in Telesis Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Telesis Bio's history and understand the potential risks before investing.